Glioblastoma clinical trials

Explore recruiting glioblastoma clinical trials.

Recruiting glioblastoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Glioblastoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus standard temozolomide chemoradiotherapy in patients with newly diagnosed glioblastoma.

Germany, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Imaging Perfusion Restrictions from Extracellular Solid Stress - An open-label losartan study (ImPRESS)

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter randomized double-blinded controlled phase 2 study evaluating the efficacy of valganciclovir as add-on therapy in glioblastoma patients

Sweden, Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase Ib Dose Finding Study of [177Lu]Lu-NeoB in Combination with RT and TMZ in Newly Diagnosed Glioblastoma and as a Single Agent in Recurrent Glioblastoma

Spain, Italy, France, Portugal, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma as a Single Agent.

France, Spain, Portugal

Human Pharmacology (Phase I)- Other EU CTIS Study details

Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Glioblastoma trials by city

Glioblastoma in Toronto Glioblastoma in Vancouver Glioblastoma in Montreal Glioblastoma in Calgary Glioblastoma in Edmonton Glioblastoma in Ottawa Glioblastoma in Winnipeg Glioblastoma in Quebec City Glioblastoma in Hamilton Glioblastoma in Kitchener Glioblastoma in London Glioblastoma in Halifax Glioblastoma in New York Glioblastoma in Los Angeles Glioblastoma in Chicago Glioblastoma in Houston

Other conditions

Lung cancer Non-small cell lung cancer Colorectal cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Bladder cancer Kidney cancer Liver cancer Head and neck cancer Cervical cancer Endometrial cancer Gastric cancer Age-related macular degeneration Diabetic retinopathy Glaucoma Dry eye disease HIV Hepatitis B Hepatitis C COVID-19